Market Movers: RXi Pharmaceuticals Corporation (NASDAQ:RXII), Neuralstem, Inc. (NYSEMKT:CUR), Insulet Corporation (NASDAQ:PODD), Cisco Systems, Inc. (NASDAQ:CSCO), Ericsson (NASDAQ:ERIC)

RXi Pharmaceuticals Corporation (NASDAQ:RXII) belongs to Healthcare sector. Its weekly performance is -13.33%. On last trading day company shares ended up $0.46. RXi Pharmaceuticals Corporation (NASDAQ:RXII) distance from 50-day simple moving average (SMA50) is -36.86%. RXi Pharmaceuticals Corp. (NASDAQ:RXII) is seeking to raise about $25 million through the sale of 22.5 million units of common stock and warrants, according to a filing with the Securities and Exchange Commission. RXi, a biotechnology company working on a treatment to prevent scarring, said it plans to use money from the sale for general corporate purposes.

Neuralstem, Inc. (NYSEMKT:CUR) shares advanced 2.52% in last trading session and ended the day at $1.63. CUR return on assets is -71.50%. Neuralstem, Inc. (NYSEMKT:CUR) quarterly performance is -55.71%. Neuralstem Inc. (NYSE:CUR)‘s stock had its “buy” rating restated by equities researchers at Brean Capital in a research report.

On 27 May, Insulet Corporation (NASDAQ:PODD) shares advanced 1.26% and was closed at $28.06. PODD EPS growth in last 5 year was 17.50%. Insulet Corporation (NASDAQ:PODD) year to date (YTD) performance is -39.08%. An investor, who purchased shares of Insulet Corporation (NASDAQ:PODD), on 11 May, filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Insulet Corporation.

Cisco Systems, Inc. (NASDAQ:CSCO) shares moved up 1.24% in last trading session and ended the day at $29.31. CSCO Gross Margin is 60.30% and its return on assets is 8.50%. Cisco Systems, Inc. (NASDAQ:CSCO) quarterly performance is 0.15%. The U.S. Supreme Court on Tuesday ruled against Cisco Systems Inc. (NASDAQ:CSCO) over a patent infringement claim the tech giant is fighting. On a 6-2 vote, with Justice Stephen Breyer recused from the case, the court threw out a ruling by the U.S. Court of Appeals for the Federal Circuit in favor of Cisco. There is now likely to be a new trial.

On 27 May, Ericsson (NASDAQ:ERIC) shares remains unchanged and was closed at $11.10. ERIC EPS growth in last 5 year was 25.20%. Ericsson (NASDAQ:ERIC) year to date (YTD) performance is -5.37%.Ericsson (NASDAQ:ERIC) said that it is open to a transaction to counter a move by rivals Nokia and Alcatel-Lucent to combine and overtake the Swedish company as a leading provider of network equipment.

Leave a Reply

Your email address will not be published. Required fields are marked *